TOP

Fapon Presents IVD Innovations at MEDICA 2018

Date: 2018-11-13
Views: 128

(Dongguan, China, 13 November 2018) Fapon Biotech Inc. (Fapon) joins the biggest medical event MEDICA in Germany from 12th to 15th November at booth H3-A81 to present the latest offerings and upcoming innovations.

 

It’s the time of the year MEDICA once again opens its door to healthcare experts and decision-makers who have a high desire to showcase and exchange innovations. Being a part of this large medical community, Fapon continues to thrive and network with global partners, showing how long-term collaboration is formed and generate particle value on the healthcare environment.

 

Fapon Presents IVD Innovations at MEDICA 2018

 

“While companies are increasing their investments in emerging economies like China and Brazil, we would like to speak out on how our comprehensive product and service portfolio can help our partners to capture opportunities in the downstream market, therefore this year we had extended our brand presence in the Messe Düsseldorf beside traditional booth presentation”, Fapon Management Team pointed out.


Fapon Presents IVD Innovations at MEDICA 2018

Product extension is recognized as one of the key focuses of Fapon’s R&D department. In MEDICA, Fapon shared the update of 16 new IVD reagent raw materials, which include tumor, cardiac and hormone markers for ELISA and CLIA platforms.


Fapon Presents IVD Innovations at MEDICA 2018


Fapon Presents IVD Innovations at MEDICA 2018


Fapon Presents IVD Innovations at MEDICA 2018

 

In addition to the vast product range of IVD reagent raw materials, serious one-stop solutions are also showcased in Fapon’s booth. Six newly developed reagents are added to the Immunofluorescent POCT solution, forming an extensive test category that covers Cardiac, Thrombosis, Infection, Renal Injury, Pregnancy, Thyroid, Hormone and Diabetes.

 

Fapon Presents IVD Innovations at MEDICA 2018

Owing to Fapon’s proven experience and techniques in IVD raw materials development and manufacturing, the other one-stop solutions, CLIA/CLEIA, Immunoturbidimetric and ELISA reagent development have also generated a lot of buzz since test accuracy in the downstream market are heavily rely on the raw materials used, choosing a quality upstream IVD partner is critical in businesses. 


 Fapon Presents IVD Innovations at MEDICA 2018


 


form>